to VD3 plays a critical role in modifying the IL-17 pathway in mucosal ILC3s47. Further identification of modulators of ILC function may be of interest for the design of therapeutic interventions, especially those targeting the downstream or upstream pathways that regulate ILC activation and ...
Thus, the identification of tumor antigens and of immunogenic tumor peptides allowed the development of tumor vaccines to better target tumor cells. On the other hand, NK cell ability to kill MHC class I defective tumors has been exploited in different adoptive cell therapy approaches, including ...